SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5) announced it has raised US$57.5 ...

Vertex Minerals Limited (ASX:VTX) announced the early closure of its Share Purchase Plan (SPP) on June 6, 2025, after ...

San Jose, USA-based biotech Allay Therapeutics today announced the completion of a $57.5 million Series D financing round ...

Vertex Pharmaceuticals has caught investors’ eyes, but its stock performance isn’t exactly a mic-drop moment. Despite massive ...

Vertex Pharmaceuticals's VRTX short percent of float has risen 27.71% since its last report. The company recently reported ...

Short interest in Vertex Pharmaceuticals jumped 27.5% in May, hitting 4.82 million shares—just under 2% of the float. This ...

Stakeholders agree that the regulatory overhaul sends a strong signal to both local and international investors, positioning ...

Some investors are staying away from the market right now due to the volatility stocks have experienced this year and the ...

One stock that divides many investors at this time is Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG). Early on, the company built up ...

Trillion-dollar market valuations remain a rare milestone, typically only achieved through extraordinary corporate success ...

Vertex has built its earnings thanks to its CF program, and with a new CF drug approved a few months ago, the company may be ...

After a rough start to the year, small- and mid-cap software stocks may be finding their footing. Goldman Sachs analyst Adam Hotchkiss says first-quarter results across his coverage were better than ...